Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 · New England Journal of Medicine · 21K citations
https://doi.org/10.1056/nejmoa043330
A
Alba A. Brandes
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
647
Papers
62.9K
Citations
85
h-index
281
i10-index
Alba A. Brandes is an academic researcher from Istituto delle Scienze Neurologiche di Bologna. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Brain Metastases and Treatment & Radiomics and Machine Learning in Medical Imaging. The author has an h-index of 85, co-authored 550 publications.
ORCID: 0000-0002-2503-9089Papers by this author
worksEffects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
2009 · The Lancet Oncology · 7,668 citations
https://doi.org/10.1016/s1470-2045(09)70025-7
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
2017 · New England Journal of Medicine · 1,136 citations
https://doi.org/10.1056/nejmoa1611977
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
2014 · The Lancet Oncology · 1,001 citations
https://doi.org/10.1016/s1470-2045(14)70379-1
Lomustine and Bevacizumab in Progressive Glioblastoma
2017 · New England Journal of Medicine · 949 citations
https://doi.org/10.1056/nejmoa1707358
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?
2009 · Nature Reviews Neurology · 774 citations
https://doi.org/10.1038/nrneurol.2009.197
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat